Haematuria_Alport

Gene: COL4A4

Green List (high evidence)

COL4A4 (collagen type IV alpha 4 chain)
EnsemblGeneIds (GRCh38): ENSG00000081052
EnsemblGeneIds (GRCh37): ENSG00000081052
OMIM: 120131, Gene2Phenotype
COL4A4 is in 8 panels

1 review

Ee Ming Wong (Victorian Clinical Genetics Services)

Green List (high evidence)

AR Alport Syndrome: > 3 unrelated families (PMID: 24052634)
TBMN: > 3 unrelated families (PMID:12631110)
FSGS: 2 unrelated families (PMID: 17942953; 26346198)

There are reports suggesting heterozygous COL4A4 mutations can cause AD Alport Syndrome, but there is still uncertainty surrounding this observation (PMID: 30450445)
Created: 1 May 2020, 12:34 a.m. | Last Modified: 1 May 2020, 12:34 a.m.
Panel Version: 0.32

Mode of inheritance
BOTH monoallelic and biallelic (but BIALLELIC mutations cause a more SEVERE disease form), autosomal or pseudoautosomal

Phenotypes
Alport syndrome 2, autosomal recessive, 203780; Thin basement membrane nephropathy (TBMN), AD; Focal segmental glomerulosclerosis (FSGS), AD

Publications

Details

Mode of Inheritance
BOTH monoallelic and biallelic (but BIALLELIC mutations cause a more SEVERE disease form), autosomal or pseudoautosomal
Sources
  • Expert Review Green
  • Victorian Clinical Genetics Services
Phenotypes
  • Alport syndrome 2, autosomal recessive, 203780
  • Thin basement membrane nephropathy (TBMN), AD
  • Focal segmental glomerulosclerosis (FSGS), AD
Tags
Medicare
OMIM
120131
Clinvar variants
Variants in COL4A4
Penetrance
None
Publications
Panels with this gene

History Filter Activity

1 May 2020, Gel status: 3

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Gene: col4a4 has been classified as Green List (High Evidence).

1 May 2020, Gel status: 3

Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Phenotypes for gene: COL4A4 were changed from to Alport syndrome 2, autosomal recessive, 203780; Thin basement membrane nephropathy (TBMN), AD; Focal segmental glomerulosclerosis (FSGS), AD

1 May 2020, Gel status: 3

Set publications

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Publications for gene: COL4A4 were set to

1 May 2020, Gel status: 3

Set mode of inheritance

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Mode of inheritance for gene: COL4A4 was changed from Unknown to BOTH monoallelic and biallelic (but BIALLELIC mutations cause a more SEVERE disease form), autosomal or pseudoautosomal

5 Feb 2020, Gel status: 3

Added Tag

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Tag Medicare tag was added to gene: COL4A4.

17 Nov 2019, Gel status: 3

Created, Added New Source, Set mode of inheritance

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

gene: COL4A4 was added gene: COL4A4 was added to Alport syndrome extended_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services Mode of inheritance for gene: COL4A4 was set to Unknown